Europe · Agences & temps réel · Reuters US Markets

Swiss drug developer Windward Bio files for US IPO

Publié par Reuters US Markets · Royaume-Uni il y a 10 h

Windward Bio filed for a US initial public offering on Friday, becoming the latest drug developer seeking to capitalize on renewed ‌investor interest in biotech listings.

Lire l'article complet sur Reuters US Markets Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.reuters.com)

Swiss drug developer Windward Bio files for US IPO

À lire aussi

La 19e Foire de coopération économique et technologique Europe–Chine s'ouvre à Chengdu

Saudi Arabia not to host Intervision this year — TASS source

New York stock market closes week lower

AI 'hallucinations' in court filings show signs of slowdown, but judges still sound alarms

Fastmarkets proposes calculated FOB South America lithium carbonate, hydroxide prices

What is going on with SpaceX's Starlink and Starshield in Ukraine?

Swiss drug developer Windward Bio files for US IPO

Partager

À lire aussi

La 19e Foire de coopération économique et technologique Europe–Chine s'ouvre à Chengdu

Saudi Arabia not to host Intervision this year — TASS source

New York stock market closes week lower

AI 'hallucinations' in court filings show signs of slowdown, but judges still sound alarms

Fastmarkets proposes calculated FOB South America lithium carbonate, hydroxide prices

What is going on with SpaceX's Starlink and Starshield in Ukraine?